Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Summit Therapeutics Inc. (SMMT)

17.61 +0.48 (+2.77%)
At close: September 4 at 4:00:00 PM EDT
17.63 +0.02 (+0.12%)
After hours: September 4 at 7:59:13 PM EDT
Trade SMMT on Coinbase

News headlines

Updated 9m ago
Powered by Yahoo Scout

Summit Therapeutics is gaining momentum with promising Phase III results for its drug ivonescimab, showing significant survival benefits in cancer treatments. The upcoming FDA decision on November 14, 2026, will be crucial for its future commercial prospects.

Mobilize your Website
View Site in Mobile | Classic
Share by: